Bioscan Research has developed a non-invasive device for detecting intracranial haemorrhage.

Basic Information

Bioscan Research is leveraging deep tech in optics, electronics, mechanics and software to develop, test, manufacture and commercialize affordable medical devices for early detection of life-threatening diseases non-invasively. Their product, CEREBO's, novel application of near infrared spectroscopy makes it possible to detect intracranial hemorrhage non-invasively. It is an established science that correlates optical density of near infrared light with hemoglobin concentration. The self-calibration and intuitive user interface makes the device very easy to use. The miniaturised hardware is designed to bridge the limitations of traditional tools that are bulky, expensive, and need much greater infrastructure support like air conditioning to provide point-of-care detection that will assist in triaging suspected TBI patients in military, sports, and emergency or urgent care environments both in India and internationally. CEREBO’s proprietary optoelectronic configuration deploying diffuse reflectance spectroscopy detects the presence of intracranial hemorrhage non-invasively. See more

Legal Name

:

Bioscan Research Pvt Ltd.

Headquarters

:

Ahmedabad, Gujarat, India

Founding Date

:

2013

No. of Employees

:

<10

Core Team

:
1.

Shilpa Malik Lavania

Founder & CTO

2.

Anupam Lavania

Founder & CEO

Funding

Investors

:

1.

Unitus Ventures

2.

iCreate

3.

Indian Institute of Technology Kanpur

See More